{"id":938412,"date":"2026-02-19T16:06:00","date_gmt":"2026-02-19T21:06:00","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\/"},"modified":"2026-02-19T16:06:00","modified_gmt":"2026-02-19T21:06:00","slug":"levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\/","title":{"rendered":"Levi & Korsinsky Notifies Shareholders of REGENXBIO Inc.(RGNX) of a Class Action Lawsuit and an Upcoming Deadline"},"content":{"rendered":"
\n

NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in REGENXBIO Inc.<\/strong> (“REGENXBIO” or the “Company”) (NASDAQ: RGNX) of a class action securities lawsuit.<\/p>\n

\n CLASS DEFINITION: <\/strong>The lawsuit seeks to recover losses on behalf of REGENXBIO investors who were adversely affected by alleged securities fraud between February 9, 2022 and January 27, 2026. Follow the link below to get more information and be contacted by a member of our team:<\/p>\n

\n https:\/\/zlk.com\/pslra-1\/regenxbio-inc-lawsuit-submission-form?prid=183670&wire=3<\/a>\n <\/p>\n

\n RGNX<\/strong> investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com<\/a>\u00a0or by telephone at (212) 363-7500.<\/p>\n

\n CASE DETAILS: <\/strong>According to the complaint, defendants provided investors with material information concerning REGENXBIO\u2019s plan to develop and commercialize its product candidate RGX-111, a one-time gene therapy for the treatment of severe Mucopolysaccharidosis Type I, also known as Hurler syndrome. Defendants\u2019 statements included, among other things, REGENXBIO\u2019s positive assertions of RGX-111\u2019s future trial success based on continuing positive biomarker and safety data from the ongoing PhaseI\/II study. 3. Defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating false and misleading statements and\/or concealing material adverse facts concerning the efficacy and safety of its RGX-111 trial study. On January 28, 2026, REGENXBIO issued a press release announcing that the FDA placed a clinical hold on its investigational gene therapy RGX-111. Defendants announced that an intraventricular CNS tumor was found in a participant treated in its RGX-111 Phase I\/II study. Following this news, the price of REGENXBIO\u2019s common stock declined from a closing market price of $13.41 per share on January 27, 2026, REGENXBIO\u2019s stock price fell to $11.01 per share on January 28, 2026, a decline of 17.8% in the span of just a single day.<\/p>\n

\n WHAT’S NEXT? <\/strong>If you suffered a loss in REGENXBIO during the relevant time frame, you have until April 14, 2026<\/strong>\u00a0to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.<\/p>\n

\n NO COST TO YOU: <\/strong>If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.<\/strong><\/p>\n

\n WHY LEVI & KORSINSKY: <\/strong>Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services\u2019 Top 50 Report as one of the top securities litigation firms in the United States.<\/p>\n

\n CONTACT:<\/strong>
\n
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com<\/a>
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in REGENXBIO Inc. (“REGENXBIO” or the “Company”) (NASDAQ: RGNX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of REGENXBIO investors who were adversely affected by alleged securities fraud between February 9, 2022 and January 27, 2026. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/regenxbio-inc-lawsuit-submission-form?prid=183670&wire=3 RGNX investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: According to the complaint, defendants provided investors with material information concerning REGENXBIO\u2019s plan to develop and commercialize its product candidate RGX-111, a one-time gene therapy … <\/p>\n

Continue reading “Levi & Korsinsky Notifies Shareholders of REGENXBIO Inc.(RGNX) of a Class Action Lawsuit and an Upcoming Deadline”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-938412","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nLevi & Korsinsky Notifies Shareholders of REGENXBIO Inc.(RGNX) of a Class Action Lawsuit and an Upcoming Deadline - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Levi & Korsinsky Notifies Shareholders of REGENXBIO Inc.(RGNX) of a Class Action Lawsuit and an Upcoming Deadline - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in REGENXBIO Inc. (“REGENXBIO” or the “Company”) (NASDAQ: RGNX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of REGENXBIO investors who were adversely affected by alleged securities fraud between February 9, 2022 and January 27, 2026. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/regenxbio-inc-lawsuit-submission-form?prid=183670&wire=3 RGNX investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: According to the complaint, defendants provided investors with material information concerning REGENXBIO\u2019s plan to develop and commercialize its product candidate RGX-111, a one-time gene therapy … Continue reading "Levi & Korsinsky Notifies Shareholders of REGENXBIO Inc.(RGNX) of a Class Action Lawsuit and an Upcoming Deadline"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-19T21:06:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1Nzg0MiM3NDM1MDIwIzIwMjA0MjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Levi & Korsinsky Notifies Shareholders of REGENXBIO Inc.(RGNX) of a Class Action Lawsuit and an Upcoming Deadline\",\"datePublished\":\"2026-02-19T21:06:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\\\/\"},\"wordCount\":492,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1Nzg0MiM3NDM1MDIwIzIwMjA0MjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\\\/\",\"name\":\"Levi & Korsinsky Notifies Shareholders of REGENXBIO Inc.(RGNX) of a Class Action Lawsuit and an Upcoming Deadline - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1Nzg0MiM3NDM1MDIwIzIwMjA0MjY=\",\"datePublished\":\"2026-02-19T21:06:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1Nzg0MiM3NDM1MDIwIzIwMjA0MjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1Nzg0MiM3NDM1MDIwIzIwMjA0MjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Levi & Korsinsky Notifies Shareholders of REGENXBIO Inc.(RGNX) of a Class Action Lawsuit and an Upcoming Deadline\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Levi & Korsinsky Notifies Shareholders of REGENXBIO Inc.(RGNX) of a Class Action Lawsuit and an Upcoming Deadline - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\/","og_locale":"en_US","og_type":"article","og_title":"Levi & Korsinsky Notifies Shareholders of REGENXBIO Inc.(RGNX) of a Class Action Lawsuit and an Upcoming Deadline - Market Newsdesk","og_description":"NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in REGENXBIO Inc. (“REGENXBIO” or the “Company”) (NASDAQ: RGNX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of REGENXBIO investors who were adversely affected by alleged securities fraud between February 9, 2022 and January 27, 2026. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/regenxbio-inc-lawsuit-submission-form?prid=183670&wire=3 RGNX investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: According to the complaint, defendants provided investors with material information concerning REGENXBIO\u2019s plan to develop and commercialize its product candidate RGX-111, a one-time gene therapy … Continue reading \"Levi & Korsinsky Notifies Shareholders of REGENXBIO Inc.(RGNX) of a Class Action Lawsuit and an Upcoming Deadline\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\/","og_site_name":"Market Newsdesk","article_published_time":"2026-02-19T21:06:00+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1Nzg0MiM3NDM1MDIwIzIwMjA0MjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Levi & Korsinsky Notifies Shareholders of REGENXBIO Inc.(RGNX) of a Class Action Lawsuit and an Upcoming Deadline","datePublished":"2026-02-19T21:06:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\/"},"wordCount":492,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1Nzg0MiM3NDM1MDIwIzIwMjA0MjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\/","name":"Levi & Korsinsky Notifies Shareholders of REGENXBIO Inc.(RGNX) of a Class Action Lawsuit and an Upcoming Deadline - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1Nzg0MiM3NDM1MDIwIzIwMjA0MjY=","datePublished":"2026-02-19T21:06:00+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1Nzg0MiM3NDM1MDIwIzIwMjA0MjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1Nzg0MiM3NDM1MDIwIzIwMjA0MjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-notifies-shareholders-of-regenxbio-inc-rgnx-of-a-class-action-lawsuit-and-an-upcoming-deadline\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Levi & Korsinsky Notifies Shareholders of REGENXBIO Inc.(RGNX) of a Class Action Lawsuit and an Upcoming Deadline"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/938412","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=938412"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/938412\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=938412"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=938412"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=938412"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}